Las Vegas, NV -- (SBWIRE) -- 09/27/2013 -- PennyStockParlay.com Our process for picking penny stocks is not only unconventional, but untapped, undiscovered, and also exclusive. To keep our picks consistent with how only the "Best Penny Stocks" perform in the penny stock market, we have to keep our penny stock picks producing large and consistent gains.Have a look at today’s active stocks: MC-Sierra Inc(NASDAQ:PMCS), Orexigen Therapeutics, Inc.(NASDAQ:OREX), Array Biopharma Inc(NASDAQ:ARRY), Grupo Financiero Galicia S.A. (ADR)(NASDAQ:GGAL)
MC-Sierra Inc(NASDAQ:PMCS) reported unchanged and closed at $6.69 with the total traded volume of 1.28M shares. Its market capitalization is $ 1.37 B. The stock has a 52-week high price of $7.14 and its 52-week low was recorded at $4.63
PMC-Sierra, Inc., is a semiconductor innovator transforming networks that connect, move and store digital content. The Company designs, develops, markets and supports semiconductor solutions by integrating its mixed-signal, software and systems through a network of offices in North America, Europe and Asia.
What PMCS Charts Are Signaling for Traders? Find Out Here
Orexigen Therapeutics, Inc.(NASDAQ:OREX) gained 3.50% and ended at $6.51.The total traded volume was 1.26M shares and market capitalization arrived at $644.31 million. The stock has a 52-week high price of $7.84 and its 52-week low was recorded at $3.91, while during last trade its minimum price was $6.28 and it gained the highest price of $6.54.
Orexigen Therapeutics, Inc. develops drug treatments for obesity and related disorders. Orexigen Therapeutics, Inc. develops and commercializes combinations of currently available drugs that are designed to achieve and sustain weight loss by enhancing satiety, diminishing appetite, improving energy expenditure and minimizing the body's efforts to compensate for weight loss.
Is OREX Buy After The Recent Price Movement? Find Out Here
Array Biopharma Inc(NASDAQ:ARRY)’s reported loss -0.50% and close at $5.97 with the overall traded volume of 1.24M shares. Its market capitalization on last close reached to $698.60 million. The company has the total of 117.02 million outstanding shares. Its intraday-low price was $5.93 and its hit its day's highest price at $6.09.
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs to treat patients afflicted with cancer and inflammatory diseases.
Should ARRY a Buy or Sell Now? Find Out Here
Grupo Financiero Galicia S.A. (ADR)(NASDAQ:GGAL) increase 1.89% settle at $9.72. Its total traded volume during last trading session was 1.22M shares. The overall market worth of this company is about $1.21 billion. The 52 week range of the stock remained $4.54 - $9.93, while its day's lowest price was $9.55 and its hit its day's highest price at $9.93.
Grupo Financiero Galicia SA is an Argentina-based financial services holding company. Banco de Galicia y Buenos Aires SA is the Company’s major asset, which provides a range of financial products and services to large corporations, small and medium sized companies (SMEs), and individuals.
What GGAL Charts Are Signaling for Traders? Find Out Here
Penny stocks are stocks that can be traded in the stock market at a very cheap price. The investor who decides to buy penny stocks should have a substantial intellect of the market and should be bequeathing to possibly suffer a loss in money. The phrase penny stock is usually used for stock dealing that does not imply the greater and popularly known exchanges.
The disclaimer is to be read and fully understood before using our site, or joining our newsletter email list. Never invest into a stock discussed on this web site or the PennyStockParlay.comnewsletter unless you can afford to lose your entire investment.
Please consult with a certified financial advisor before making any investment decisions.
PennyStockParlay.com and any affiliates and information providers make no implied or express warranties on the information provided. Please verify quotes with your investment manager before making investment decisions. This is not to be construed as a solicitation to buy or sell securities. As with any stock, the featured companies in the profiled on the PennyStockParlay.com web site and/or newsletter involve a high degree of risk and volatility, and all investors should know that they may lose a portion or all of their investment if they decide to purchase any stock.
Read Full Disclaimer at: http://pennystockparlay.com/disclaimer.html
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)